Income Statement
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $114K | — | +81.0% |
| Cost of Revenue | $45K | — | +0.0% |
| Gross Profit | $69K | — | +287.3% |
| R&D Expense | $236K | — | +171.8% |
| SG&A Expense | $0 | — | -100.0% |
| Operating Income | -$3.9M | — | +3.5% |
| Pre-tax Income | -$4.0M | — | -17.5% |
| Income Tax | $0 | — | — |
| Net Income | -$4.0M | — | -17.5% |
| EPS (Basic) | -$0.65 | — | +41.4% |
| EPS (Diluted) | -$0.65 | — | +41.4% |
Balance Sheet
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $51K | -92.5% | — |
| Current Assets | $5.9M | -19.6% | +27.0% |
| Total Assets | $19.8M | +22.5% | +47.1% |
| Current Liabilities | $1.8M | +2.8% | -67.8% |
| Long-term Debt | $150K | +0.0% | — |
| Total Liabilities | $2.2M | +5.9% | -63.1% |
| Stockholders' Equity | $17.2M | +26.7% | +165.1% |
Cash Flow
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | +25.7% |
| Investing Cash Flow | $592K | — | — |
| Financing Cash Flow | $704K | — | -88.5% |